Zim Laboratories Share Price Today

Zim Laboratories incorporates Chile subsidiary for LATAM expansion

Zim Laboratories incorporated ZIM Laboratories SpA in Chile on September 9, 2026. The wholly owned subsidiary aims to expand pharmaceutical business in LATAM. Parent company subscribed 14,100 shares at CLP 1,000 face value each. Transaction involved cash consideration with no regulatory approvals required.

Zim Laboratories shareholders approve revised remuneration for top executives

Zim Laboratories Limited secured shareholder approval for revised remuneration packages for MD Dr. Anwar Daud and WTD Mr. Zulfiqar Kamal via postal ballot. Both special resolutions passed with over 99.98% support. Promoters voted unanimously in favour, while public non-institutional investors, though participating at a lower rate, provided substantial vote volume.

Zim Laboratories makes Q1 FY27 earnings call audio available

Zim Laboratories Limited disclosed the availability of its Q1 FY27 earnings call audio recording on August 8, 2026. Filed under SEBI Regulation 30, the recording captures management's insights into the company's financial results and strategic outlook for the fiscal year.

Zim Laboratories Q1FY27: Net loss widens to ₹401.70 lakh despite 31% revenue growth

Zim Laboratories reported a widened consolidated net loss of ₹401.70 lakh in Q1FY27, despite a 31.2% YoY revenue surge to ₹9,417.85 lakh. Rising employee benefits and a sharp fall in other income drove margin compression.

Zim Laboratories Q1 Results: Net Loss Widens to ₹40M, Revenue Up YoY

Zim Laboratories posted Q1 consolidated net loss of 40M rupees, widening from a loss of 19M rupees in the same quarter last year. Revenue improved to 942M rupees from 717M rupees YoY, but EBITDA fell to 25M rupees from 42M rupees over the same period. The EBITDA margin contracted sharply to 2.60% from 5.90% YoY, highlighting significant pressure on operating profitability despite topline growth.

Zim Laboratories opens remote e-voting for director pay revision

Zim Laboratories Limited has initiated the remote e-voting process to seek shareholder approval for revising the remuneration structure of its Managing Director and Whole-Time Director. The postal ballot notice was dispatched on July 10, 2026, and the company has submitted the newspaper publication details to the exchanges. The proposed remuneration includes a fixed pay of up to ₹3.00 crore for the Managing Director and ₹2.50 crore for the Whole-Time Director, along with performance-linked incentives. The voting period is scheduled from July 13, 2026, to August 11, 2026.